UNMC update PLUS Drugs to Treat COVID-19

NCER Comments:

As part of an NIH randomized, placebo-controlled clinical trial, UNMC is currently studying the effects of the antiviral drug Remdesivir on COVID-19 patients. Outcomes seen as quickly as within 15 days are being monitored by a national independent safety board, and the unofficial results are positive so far. The UNMC “Quarantine Unit” (in addition to the critical care “Biocontainment Unit”) holds room for 20 patients who are among the first to be included …